Clinical study of ultrasound assisted celiac plexus destruction in the treatment of advanced upper abdominal cancer pain

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058854

Enrollment

Unknown

Registered

2022-04-18

Start date

2019-01-01

Completion date

Unknown

Last updated

2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Experimental group:Ultrasound assisted celiac plexus destruction

Eligibility

Sex/Gender

All

Age

36 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. Upper abdominal tumor diagnosed by histology or imaging; 2. Abdominal pain visual analog scale (VAS) score greater than 7; 3. Painkillers are ineffective or cannot be used due to adverse reactions of painkillers; 4. The tumor cannot be removed surgically; 5. Radiotherapy or chemotherapy cannot relieve pain.

Exclusion criteria

Exclusion criteria: 1. The general condition of patients is poor; 2. Uncorrectable coagulation dysfunction; 3. Drug addiction; 4. Cannot tolerate alcohol.

Design outcomes

Primary

Measure	Time frame
Visual analog scale;	—

Countries

China

Contacts

Public ContactMo jiaquan

Zhaoqing Hongqiang Rehabilitation Hospital

yfemjq@163.com+86 13413844947

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026